We Accept amex

Formerly known as Maylips.com

info@directdoctorsupply.com+1-800-325-7104

Logo Logo
Track delivery Wishlist
  • 0 $ 0.00
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KARISMA
    • LEMONBOTTLE
    • LANLUMA
    • LIPORASE®
    • MEDIDERMA®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
Logo Logo
Menu
Close
Wishlist
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • BOTULAX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INNOTOX®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KAIMAX
    • KARISMA
    • LEMONBOTTLE
    • LETYBO®
    • LANLUMA
    • LIPORASE®
    • LIZTOX®
    • MEDIDERMA®
    • MEDITOXIN®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NABOTA® (JEUVEAU®)
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • Re N Tox™
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
  • 0 $ 0.00
Direct Doctor SupplyPeptides for ResearchLongevity & Anti-Aging PeptidesSS-31
Product Category
  • Anaesthetics (2)
  • Body Sculpting (4)
  • Botulinum Toxins (33)
  • Cannulas and Needles (13)
  • Cellular Rejuvenation (1)
  • Dermal Filler Removal (2)
  • Dermal Fillers (192)
  • Biostimulators (10)
  • HA Dermal Fillers (129)
  • Korean Dermal Fillers (28)
  • Polynucleotides (17)
  • Skinboosters (16)
  • Exosomes (1)
  • Eyelash Enhancers (1)
  • Fat Removal (3)
  • Gynecology (8)
  • IV Therapy (2)
  • Mesotherapy (23)
  • Orthopedic Injections (11)
  • Peels and Masks (23)
  • Peptides for Research (45)
  • Aesthetic & Cosmetic Peptides (1)
  • Brain, Cognitive & Nootropic Peptides (4)
  • Healing & Regenerative Peptides (6)
  • Immune & Thymic Peptides (4)
  • Longevity & Anti-Aging Peptides (7)
  • Muscle Growth & Performance Peptides (11)
  • Sexual Health & Hormonal Peptides (3)
  • Weight Loss & Metabolic Peptides (11)
  • PRP Kits (1)
  • Skincare (26)
  • Threads (28)
  • PCLA Threads (3)
  • PDO Threads (20)
  • PLA Threads (3)
  • Weight Loss (24)
Product Brand
  • ALIAXIN® (6)
  • ALIDYA™ (1)
  • AQUALYX® (1)
  • AZZALURE® (1)
  • BCN (12)
  • BELLAST® (3)
  • BELOTERO® (7)
  • BIOMEDICO (3)
  • BIOREPEELCL3® (2)
  • BOCOUTURE® (XEOMIN®) (3)
  • BOTOX® (6)
  • CAREGEN (2)
  • CINGAL® (1)
  • CRESPINE® (1)
  • CROMA (4)
  • CYTOCARE (4)
  • DEPO-PROVERA® (1)
  • DERMALAX™ (3)
  • DESIRIAL® (2)
  • DUROLANE® (1)
  • DYSPORT® (4)
  • EJAL (1)
  • ELLANSÉ™ (2)
  • EMLA™ (2)
  • EUFLEXXA® (1)
  • EXOJUV (1)
  • FILLMED® (14)
  • FILORGA® (2)
  • GARDASIL® (1)
  • HArmonyCA™ (1)
  • HYACORP (5)
  • HYAFILIA® (2)
  • HYALGAN® (1)
  • HYMOVIS® (1)
  • HYNIDASE® (1)
  • INTRALINE® (24)
  • JALUPRO® (5)
  • JAYDESS® (1)
  • JUVÉDERM® (13)
  • KARISMA (1)
  • LANLUMA (1)
  • LEMONBOTTLE (1)
  • LIPORASE® (1)
  • MEDIDERMA® (26)
  • MESO-RELLE® (2)
  • MESOESTETIC® (2)
  • MICRONJET™ (1)
  • MIRENA® (1)
  • MONOVISC® (1)
  • MOUNJARO® (9)
  • NEAUVIA™ (11)
  • NEURAMIS® (1)
  • NEXPLANON® (2)
  • NITHYA (3)
  • NOVERA COMPOUNDS (46)
  • NUCLEOFILL™ (8)
  • ORTHOVISC® (1)
  • OZEMPIC® (8)
  • PERFECTHA® (4)
  • PLASMOLIFTING™ (1)
  • PLINEST® (5)
  • PROFHILO® (3)
  • ​PROSTROLANE® (1)
  • PRX-T33® (1)
  • RADIESSE® (3)
  • RAINBOW (7)
  • REFINE (3)
  • REJURAN® (3)
  • REJUVANAD+ (2)
  • RENEFIL (3)
  • RESTYLANE® (10)
  • REVANESSE® (6)
  • REVOFIL (9)
  • REVOLAX™ (4)
  • SAXENDA® (1)
  • SAYPHA® (6)
  • SCULPTRA® (1)
  • SESDERMA® (10)
  • SILHOUETTE (3)
  • SMB® (1)
  • SOFTFIL® (6)
  • STYLAGE® (25)
  • SUNEKOS® (4)
  • SUPARTZ® (1)
  • SYNVISC® (2)
  • T-SAFE® (1)
  • TEOSYAL® (12)
  • ​THERASET® (1)
  • ULTRA V® (1)
  • VISCODERM® (2)
  • WEGOVY® (6)
  • XEOMEEN® (1)
  • XEOMIN® (4)
  • ZO® (3)

SS-31

Showing all 5 results

Sort By:
  • SS 31 10mg FrontSS 31 10mg Back
    SS-31 10mg
    $ 45.00
    Read More
    -+
  • Coming Soon
    SS 31 14mg FrontSS 31 14mg Back
    SS-31 14mg
    Read More
  • Coming Soon
    A small glass vial labeled "NOVERA COMPOUNDS SS-31 15 mg," with a silver cap and a white label stating "Research Use Only." The vial contains a white powder.SS 31 15mg Back
    SS-31 15mg
    Read More
  • Coming Soon
    SS 31 30mg FrontSS 31 30mg Back
    SS-31 30mg
    Read More
  • Coming Soon
    SS 31 50mg Front
    SS-31 50mg
    Read More

SS-31 (elamipretide/Forzinity) is a cardiolipin-binding tetrapeptide that targets mitochondrial dysfunction at the inner mitochondrial membrane, making it a subject of active clinical and research interest in mitochondrial medicine, cardiovascular medicine, and longevity-focused protocols. Longevity medicine specialists, cardiologists, exercise physiologists, and anti-aging clinicians evaluating SS-31 for oxidative stress reduction, exercise tolerance, and mitochondrial protection will find a structured clinical reference in the guide below that covers mechanisms, evidence base, dosing, safety, and comparisons with related compounds. Practitioners seeking sourcing guidance or documentation support for SS-31 may contact the Direct Doctor Supply support team.

What Is SS-31 Peptide & How Does It Work? Cardiolipin-Binding Mechanism

SS-31, also known by its chemical name elamipretide or trade name Forzinity, is a synthetic tetrapeptide that selectively targets cardiolipin within the inner mitochondrial membrane [1]. It is primarily investigated for mitochondrial dysfunction, oxidative stress, exercise tolerance, cardiac health, and age-related declines in cellular energy production. By stabilizing mitochondrial membrane structure and supporting the efficiency of the electron transport chain, SS-31 represents a distinct approach within mitochondrial medicine and investigative longevity protocols.

Unlike peptides that function through receptor activation or endocrine signaling, SS-31 acts directly within mitochondria by targeting cardiolipin, a phospholipid unique to the inner mitochondrial membrane [1], [2]. This membrane-level mechanism has positioned SS-31 within the growing field of mitochondrial medicine, with researchers investigating its potential across specific genetic mitochondrial conditions, cardiovascular disease, skeletal muscle dysfunction, renal impairment, and age-related declines in mitochondrial function [4].

SS-31 selectively accumulates within the inner mitochondrial membrane, achieving concentrations substantially higher than those observed in plasma [1]. Once localized, it binds cardiolipin and modulates membrane surface electrostatics to preserve the structural organization of the electron transport chain (ETC) complexes [2]. This is clinically significant because cardiolipin is highly susceptible to oxidative damage during aging and disease states: when it deteriorates, ETC complexes destabilize, electron leakage increases, and excessive mitochondrial reactive oxygen species (mROS) accumulate. SS-31 interrupts this cascade at its source, supporting efficient electron transport and ATP production [1], [2].

Cardiolipin Protection and Mitochondrial Function

The central differentiator of SS-31 lies in its cardiolipin-binding activity. Rather than acting downstream in repair pathways, the peptide targets one of the earliest structural events contributing to mitochondrial decline. Preclinical research suggests cardiolipin stabilization may [1], [2]:

  • Preserve ETC complex organization
  • Reduce electron leakage and oxidative stress
  • Maintain mitochondrial membrane potential
  • Reduce cytochrome c release
  • Support ATP production under metabolic stress

These protective effects of SS-31 have been observed across multiple experimental models involving cardiac, renal, and skeletal muscle tissue.

SS-31 and Mitochondrial Dysfunction

The relationship between SS-31 and mitochondrial dysfunction represents one of the most extensively studied aspects of the compound. Animal and cellular studies have demonstrated that mitochondrial impairment is often accompanied by cardiolipin oxidation, ETC instability, and declining ATP production [1].

Research has shown that SS-31 can restore mitochondrial bioenergetic function in several preclinical models. Findings suggest that SS-31 may support the recovery of established mitochondrial dysfunction rather than merely slowing its progression. Much of this evidence originates in preclinical models, though translation to humans has been validated in specific genetic mitochondrial conditions, with broader applications still undergoing clinical evaluation [4].

What Is SS-31 Used For? Benefits Across Exercise Tolerance, Cardiac & Skeletal Muscle

The most frequently investigated applications for SS-31 involve mitochondrial dysfunction, oxidative stress reduction, exercise tolerance, skeletal muscle protection, and cardiac support.

Exercise Tolerance

Mitochondria are the primary source of ATP during sustained physical activity, and declining mitochondrial efficiency directly reduces exercise capacity. Early human data suggest SS-31 may influence muscle strength and endurance metrics in specific clinical populations, though broad data on age-related exercise performance remains mixed [4]. Key findings include:

  • Structural ETC stabilization may improve cellular energy availability during exertion.
  • Benefits appear most consistent in populations with documented mitochondrial compromise.
  • Broad age-related performance data remains an active area of clinical investigation.

Skeletal Muscle Protection

Age-related skeletal muscle decline is strongly associated with mitochondrial dysfunction and oxidative stress. Preclinical studies have reported protective effects in models of mitochondrial myopathy and aging-associated muscle impairment 4]:

  • SS-31 may help preserve mitochondrial structure in skeletal muscle tissue
  • ATP production under metabolic stress may be supported through ETC stabilization
  • Human data outside of specific genetic conditions remain limited

Cardiac Function Support

Cardiac tissue has exceptionally high mitochondrial density, making it particularly vulnerable to mitochondrial dysfunction. Clinical trials, including the MMPOWER trials for mitochondrial myopathy and various evaluations in cardiac populations, have examined ventricular function and myocardial energetics [4]:

  • Results have varied across studies, with mixed outcomes in broad populations
  • SS-31 may influence mitochondrial efficiency within specific compromised cardiac tissues
  • Cardiovascular applications represent the most developed human dataset outside the approved indication

Renal Applications

Kidney tissue is highly dependent on mitochondrial energy production. Researchers have explored SS-31 in models of acute kidney injury (AKI) and chronic kidney disease (CKD):

  • Preclinical studies have demonstrated reduced oxidative stress and preserved mitochondrial function
  • Early human investigations have been conducted, though the evidence base remains smaller than cardiovascular and myopathy data.

SS-31 Peptide Dosage & Administration

Formal human administration of elamipretide includes both intravenous protocols evaluated in clinical trials and an established subcutaneous regimen under its approved indication. For its FDA-approved indication in Barth syndrome, the validated therapeutic regimen is a 40 mg once-daily subcutaneous injection for patients weighing at least 30 kg [5]. This is the only dosing regimen supported by formal regulatory review and prescribing information.

Outside of its approved indication, low-dose subcutaneous protocols, such as 1–10 mg daily, are frequently cited in longevity medicine literature. Practitioners should note that these lower-dose ranges represent hypothetical extrapolations from animal models or anecdotal reports, rather than data from large-scale controlled human trials for age-management applications. Any off-label dosing decision requires individualized clinical assessment and careful review of the current evidence base.

Storage and Handling

Research-grade SS-31 is typically stored lyophilized at -20°C and protected from direct light. Once reconstituted with bacteriostatic water, the solution should be stored at 2–8°C. Healthcare professionals evaluating suppliers should prioritize documentation of purity, stability data, and batch-specific testing. When buying online, quality assurance practices can vary substantially across sources, making verification of certificates of analysis and LOT traceability essential pre-procurement steps.

Safety Profile & Legal Status of SS-31

Elamipretide has demonstrated an established safety profile within its studied clinical indications [3], [5]. According to official prescribing data, the most common adverse events associated with subcutaneous administration are mild-to-moderate injection site reactions, including erythema, pain, and pruritus [5]. Broad tolerability data remains highly indication-specific, and clinicians should consider the absence of long-term safety data when discussing off-label longevity protocols [4].

IV infusion protocols evaluated in clinical trials most commonly reported mild flushing and nausea, which appear to be infusion rate-dependent and manageable with slower infusion rates. Practitioner-reported subcutaneous use outside the approved indication has been associated with transient injection site reactions comparable to those observed in the Barth syndrome trial population.

Regulatory Status

SS-31 (elamipretide) received FDA accelerated approval under the trade name Forzinity for the treatment of muscle strength in patients with Barth syndrome weighing at least 30 kg, granted September 18, 2025 [3]. However, it is not FDA-approved for general anti-aging, cardiac, or longevity indications, nor is it listed on the FDA 503A bulk substances compounding list [3], [5]. Outside of its specific approved orphan indication, elamipretide remains an investigational compound. A confirmatory trial is ongoing as part of the accelerated approval pathway [4]. Practitioners should verify the current regulatory status independently before making prescribing or procurement decisions.

Athletic Considerations

While elamipretide is not explicitly named on the World Anti-Doping Agency (WADA) Prohibited List, sports medicine practitioners must exercise caution. WADA maintains broad catch-all prohibitions under Section S2 against unapproved or investigational peptide substances, which may apply to elamipretide depending on the context of use. Furthermore, WADA’s strict limits on intravenous infusion volumes may affect specific clinical research protocols. Annual anti-doping policy verification is mandatory for any practitioner who works with competitive athletes and is considering this compound.

Sourcing SS-31: Guidance for Licensed Practitioners

SS-31 is available in its FDA-approved form (Forzinity) for its specific approved indication and is otherwise a research-grade compound. Access to either form is limited to qualified licensed medical professionals. Sourcing from verified suppliers with appropriate documentation standards is essential to ensure purity, stability, and batch consistency.

When evaluating suppliers, practitioners should confirm:

  • A valid certificate of analysis (CoA) from an accredited third-party laboratory
  • LOT number traceability for each batch
  • Lyophilized storage compliance and cold-chain integrity documentation
  • Sterility and stability data appropriate to the intended administration route

Practitioners seeking to buy SS-31 online or to identify verified research-grade suppliers may contact the Direct Doctor Supply support team for sourcing guidance and documentation. The support team can connect practitioners with suppliers meeting research-grade purity and traceability standards. For practitioners evaluating options to buy SS-31 wholesale for larger clinical or research networks, the Direct Doctor Supply support team can guide supplier comparison and documentation requirements. Contact the Direct Doctor Supply support team directly for sourcing direction.

SS-31 vs MOTS-C & NAD

SS-31 vs MOTS-C

SS-31 and MOTS-C represent two distinct approaches to mitochondrial longevity, operating at different levels of mitochondrial biology [1]. SS-31 acts directly at the mitochondrial membrane by binding cardiolipin and preventing the structural deterioration that drives mitochondrial reactive oxygen species production. MOTS-C, by contrast, activates AMPK-mediated metabolic signaling and mitochondria-to-nucleus communication, addressing the metabolic adaptation layer of mitochondrial aging.

Practitioners focused on mitochondrial membrane integrity and upstream oxidative stress may favor SS-31; those prioritizing metabolic flexibility, insulin sensitivity, and exercise mimetic effects may consider MOTS-C. Because the mechanisms are complementary rather than redundant, some longevity protocols explore combining both compounds to address structural mitochondrial protection and metabolic signaling simultaneously.

SS-31 vs NAD

The distinction between SS-31 and NAD can be understood as upstream structural protection versus downstream cofactor replenishment [1]. SS-31 operates at the cardiolipin-ETC interface, preventing the generation of mROS and preserving mitochondrial architecture before oxidative damage propagates. NAD serves as a critical cofactor supporting sirtuin activity, PARP-mediated DNA repair, and mitochondrial biogenesis, addressing the repair and regenerative layer that follows mitochondrial stress.

In comprehensive mitochondrial longevity protocols, combining upstream membrane protection with downstream repair support represents a strong mechanistic rationale. SS-31 may be prioritized when structural membrane integrity and acute oxidative burden are the primary concerns; NAD may be prioritized when broad repair capacity, energy substrate replenishment, and biogenesis support are the goals.

FAQs

1. What is the SS-31 peptide, and what is it used for?

SS-31 (elamipretide/Forzinity) is a synthetic tetrapeptide that targets cardiolipin within the inner mitochondrial membrane [1], [3]. It holds FDA accelerated approval for muscle strength in patients with Barth syndrome and is also being investigated for mitochondrial dysfunction, oxidative stress, exercise tolerance, cardiac support, and skeletal muscle protection.

2. What does SS-31 peptide do?

SS-31 accumulates in the inner mitochondrial membrane, binds cardiolipin, and stabilizes electron transport chain complexes, reducing mitochondrial reactive oxygen species and supporting ATP generation [1], [2]. Evidence spans preclinical models and human clinical investigations, including applications in cardiovascular and mitochondrial myopathy.

3. What is the SS-31 dosage?

For its approved Barth syndrome indication, elamipretide (Forzinity) is administered subcutaneously once daily at 40 mg in patients weighing at least 30 kg [5]. Off-label longevity protocols cite 1–10 mg daily subcutaneously, though these are extrapolations from animal models rather than validated human data.

4. How does SS-31 compare to MOTS-C?

SS-31 provides structural protection of the mitochondrial membrane through cardiolipin binding; MOTS-C activates AMPK-mediated metabolic signaling through mitochondria-to-nucleus communication [1]. The mechanisms target different aspects of mitochondrial aging and are considered complementary in longevity protocols.

5. How does SS-31 compare to NAD?

SS-31 protects mitochondrial structure at the membrane level; NAD replenishes cofactors supporting sirtuin activity, DNA repair, and mitochondrial biogenesis [1]. SS-31 addresses upstream structural protection while NAD supports downstream repair and regeneration.

6. Is SS-31 FDA-approved?

Yes, in a limited context. Elamipretide (Forzinity) received FDA accelerated approval in September 2025 for muscle strength in patients with Barth syndrome weighing at least 30 kg; a confirmatory trial is ongoing [3], [4], [5]. It is not approved for anti-aging, cardiac, or longevity indications and is not on the FDA 503A compounding list. SS-31 is not explicitly named on the WADA Prohibited List, though practitioners should note WADA’s broad S2 catch-all provisions.

Citations

  1. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171(8):2029-2050. doi:10.1111/bph.12461
  2. Mitchell W, Ng EA, Tamucci JD, et al. The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action. J Biol Chem. 2020;295(14):4093–4106. https://pmc.ncbi.nlm.nih.gov/articles/PMC7247319/
  3. S. Food and Drug Administration. FDA grants accelerated approval to first treatment for Barth syndrome. Published September 19, 2025. https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-treatment-barth-syndrome
  4. Zhao C, Zhuang X, Gao J. Elamipretide: The first cardiolipin-directed mitochondrial therapeutic for Barth syndrome approved under accelerated approval. Drug Discov Ther. 2026;19(6):435–436. doi:10.5582/ddt.2025.01111. https://pubmed.ncbi.nlm.nih.gov/41260682/
  5. S. Food and Drug Administration. Forzinity (elamipretide) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215244s000lbl.pdf

All content on this website is intended for informational purposes and does not constitute medical advice.

Content prepared by Direct Doctor Supply’s editorial team.

Sourcing and accuracy for this page follow our Editorial Policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published.

SVG Logo Color cropped

info@directdoctorsupply.com

+1-800-325-7104

Book a MeetingTrack delivery
Trustpilot

Supported payment providers

Visa Mastercard American Express Google Pay Apple Pay

*Apple Pay and Google Pay are available via a personalized link provided by your account manager.

🔒 Transactions on this website meet strict PCI DSS compliance for your safety.

Product authenticity guaranteed: all products are sourced from licensed distributors and traceable by LOT number.

Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
  • Sitemap
Follow Us
  • Facebook
  • Instagram
  • LinkedIn
Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
Follow Us
  • Facebook
  • Instagram
  • Linkedin
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management

All peptide products sold by Direct Doctor Supply are Research Use Only (RUO) and intended solely for laboratory and scientific research. They are not FDA-approved and not for human or veterinary use, clinical, diagnostic, or therapeutic purposes. By purchasing RUO materials, you confirm they will be handled by qualified personnel in a proper research setting and in compliance with regulations. Products must not be administered to humans or animals or represented as safe or effective for medical use. Use is at your own risk; Direct Doctor Supply assumes no liability for misuse or regulatory issues.

2026 Direct Doctor Supply All rights reserved.
Terms Of Use Privacy Policy Refund and Replacement Shipping & Delivery